Frontlight ResearchEarly access
Trial site
Icon Cancer Centre South Brisbane
- 8running trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer2 trials
- Liver and biliary tract cancer2 trials
- Lung cancer2 trials
- Prostate cancer2 trials
- Bladder cancer1 trial
- Endometrial cancer1 trial
- Metastatic breast cancer1 trial
- Ovarian cancer1 trial
- Sarcoma1 trial
- Phase
- Phase 34 trials
- Phase 13 trials
- Phase 21 trial
- Status
- Active, not recruiting4 trials
- Recruiting4 trials
- Lead sponsor
- BeOne Medicines2 trials
- Eli Lilly and Company2 trials
- Myeloid Therapeutics1 trial
- Pfizer1 trial
- Verastem, Inc.1 trial
- and 1 more
Running trials
Recruiting
Study Comparing BGB-B2033 With Sorafenib or Lenvatinib in Advanced Hepatocellular Carcinoma
Recruiting
Recruiting
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer2 recruiting
- Liver and biliary tract cancer2 recruiting
- Bladder cancer1 recruiting
- Endometrial cancer1 recruiting
- Lung cancer1 recruiting
- Ovarian cancer1 recruiting
- Sarcoma1 recruiting
Site data: ClinicalTrials.govUpdated 18 Nov 2026